Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) Short Interest Down 57.1% in May

Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) saw a large drop in short interest in May. As of May 29th, there was short interest totaling 57,741 shares, a drop of 57.1% from the May 14th total of 134,469 shares. Based on an average daily volume of 40,907 shares, the days-to-cover ratio is presently 1.4 days. Currently, 0.5% of the shares of the company are sold short.

Institutional Investors Weigh In On Hong Kong Pharma Digital Technology

A hedge fund recently bought a new stake in Hong Kong Pharma Digital Technology stock. StoneX Group Inc. bought a new position in Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 43,284 shares of the company’s stock, valued at approximately $36,000. StoneX Group Inc. owned about 0.39% of Hong Kong Pharma Digital Technology as of its most recent filing with the Securities and Exchange Commission.

Hong Kong Pharma Digital Technology Trading Down 0.2%

NASDAQ:HKPD opened at $0.45 on Friday. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.93 and a quick ratio of 2.73. Hong Kong Pharma Digital Technology has a 12-month low of $0.32 and a 12-month high of $2.58. The firm has a 50-day moving average price of $0.58 and a 200 day moving average price of $0.69.

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) last released its quarterly earnings data on Wednesday, March 18th. The company reported $0.01 earnings per share for the quarter. The company had revenue of $3.57 million for the quarter.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Hong Kong Pharma Digital Technology in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Hong Kong Pharma Digital Technology currently has an average rating of “Sell”.

Hong Kong Pharma Digital Technology Company Profile

Hong Kong Pharma is an exempted limited liability company formed under the laws of the Cayman Islands on August 17, 2023. As a holding company with no material operations of its own, Hong Kong Pharma conducts its operations through its wholly owned subsidiaries, Joint Cross Border Logistics Company Limited and V-Alliance Technology Supplies Limited, each a limited liability corporation incorporated in Hong Kong and collectively referred to as HK Subsidiaries. Our business offering consists of two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, primarily conducted through our Hong Kong subsidiary, Joint Cross Border, which we refer to as the “Supply Chain Services” division and (ii) OTC pharmaceutical cross-border procurement and distribution, primarily conducted through our Hong Kong subsidiary, V-Alliance, which we refer to as the “Procurement and Distribution” division.